---
title: "Xeltis completes enrolment in EU pivotal trial"
date: "2025-01-07T09:33:04.000Z"
publishedDate: "7 janvier 2025"
summary: "Xeltis has announced the completion of enrolment in its EU pivotal trial for aXess, its restorative vascular access conduit, in adults with end-stage renal disease. The trial is taking place in 22 centres across Europe."
importance: ""
sourceUrl: "https://interventionalnews.com/xeltis-completes-enrolment-in-eu-pivotal-trial/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2025-01-07-xeltis-completes-enrolment-in-eu-pivotal-trial"
imageUrl: "https://interventionalnews.com/wp-content/uploads/sites/13/2025/01/new-xeltis-axess-pic-featured.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/xeltis-completes-enrolment-in-eu-pivotal-trial/"
---

![Xeltis completes enrolment in EU pivotal trial](https://interventionalnews.com/wp-content/uploads/sites/13/2025/01/new-xeltis-axess-pic-featured.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/xeltis-completes-enrolment-in-eu-pivotal-trial/*

## L’essentiel

Xeltis has announced the completion of enrolment in its EU pivotal trial for aXess, its restorative vascular access conduit, in adults with end-stage renal disease. The trial is taking place in 22 centres across Europe.

## Lien source

https://interventionalnews.com/xeltis-completes-enrolment-in-eu-pivotal-trial/
